Agios Pharmaceuticals (8AP.MU) Q3 2026 Earnings

30JulConfirmed
Q1 2026
Q2 2026
Next
-1.65
-1.56
-1.47
-1.38

Details

Expected EPS
-1.3800722867600002
Actual EPS
N/A
Surprise EPS
1.38
Surprise Percent
+100%

Description

Agios Pharmaceuticals (8AP.MU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts